NASDAQ
Enliven Therapeutics, Inc. (ELVN) has a fcf yield of -8.07% as of Friday, May 29, 2026. This represents a 59.04% increase compared to its 12-month average of -19.71%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.